ET-01 in Subjects With Lateral Canthal Lines, LCL-209

Status Completed

Clinical Trial Summary

This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).

Clinical Trial Description

This product is being tested for its ability to reduce lateral canthal lines (LCL), also known as Crow's Feet. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03912805
Study type	Interventional
Source	Eirion Therapeutics Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	February 27, 2019
Completion date	October 4, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01951742` - Dose Finding Study In Subjects With Crow's Feet	Phase 2
Completed	`NCT03326856` - ET-01 in Subjects With Lateral Canthal Lines	Phase 2
Completed	`NCT03839693` - ET-01 in Subjects With Lateral Canthal Lines, LCL-208	Phase 2
Completed	`NCT00888914` - Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines	Phase 2
Active, not recruiting	`NCT06021418` - Efficacy and Safety of DKB-119 in Patients in Crow's Feet	N/A
Completed	`NCT01358695` - Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet	Phase 2
Completed	`NCT01124565` - Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults	Phase 2
Completed	`NCT00968825` - Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines	Phase 2
Recruiting	`NCT04818203` - A Study on the Anti-Wrinkle Efficacy Assessment and Safety Evaluation of the Cluster of Autologous Dermal Fibroblast on Bilateral Crow's Feet	Phase 1/Phase 2
Active, not recruiting	`NCT04985916` - ET-01 in Subjects With Lateral Canthal Lines, LCL-210	Phase 2
Completed	`NCT01064518` - Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults	Phase 2
Completed	`NCT00968942` - Efficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines	Phase 2
Completed	`NCT03655691` - ET-01 in Subjects With Lateral Canthal Lines, LCL-207	Phase 2
Completed	`NCT01124552` - A 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults	Phase 2